Active Ingredient (In Each Tablet)
Chlorpheniramine maleate 4 mg
Phenylephrine HCl 10 mg
The following Structured Product Label (SPL) was submitted to the FDA by Dolgencorp, Llc for the product Cold And Allergy (NDC 55910-962). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, stop use and ask a doctor if, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Chlorpheniramine maleate 4 mg
Phenylephrine HCl 10 mg
Antihistamine
Nasal decongestant
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
taking sedatives or tranquilizers.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
croscarmellose sodium, lactose anhydrous, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
1-888-309-9030
DG™ι health
Maximum Strength
Cold & Allergy
Chlorpheniramine maleate, 4 mg / Antihistamine
Phenylephrine HCl, 10 mg / Nasal Decongestant
Temporarily Relieves:
• Sneezing • Nasal congestion
• Runny nose • Itchy, watery eyes
Pseudoephedrine Free
48 Tablets
Actual Tablet Size
TAMPER EVIDENT: DO NOT USE IF
PACKAGE IS OPENED OR IF BLISTER
UNIT IS TORN, BROKEN OR SHOWS ANY
SIGNS OF TAMPERING
100%
Satisfaction
Guaranteed
(888)309-9030
50844 ORG031946222
DISTRIBUTED BY DOLGENCORP, LLC
100 MISSION RIDGE
GOODLETTSVILLE, TN 37072
* Please review the disclaimer below.